|
THE PHARMA REVIEW
(NOVEMBER - DECEMBER 2011) |
Ayush Herbs and Status Quo
In Herbal Industries
|
Neelesh K. Nema,
Manoj K. Dalai, Pulok K. Mukherjee*,
|
|
Abstract: Traditional or herbal medicine has a
tremendous impact in the developed as well as developing
countries because of their wide biological activities,
higher safety margin and lesser costs than the synthetic
drugs. Since herbal medicines are prepared from
materials of plant origin they are prone to
contamination, deterioration and variation in
composition. Indian traditional medicine is based on
various systems, including Ayurveda, Siddha and Unani
(ASU) from antiquity. Department of Ayurveda, Yoga &
Naturopathy, Unani, Siddha and Homoeopathy (AYUSH) under
the supervision of Government of India, with a vision to
providing quality control and standardization of drugs
and generation awareness about these systems with
upgrading educational standards at national and
international level. In India, numbers of herbal
manufacturing units are involved in benefits of human
healthcare. They are commercializing their products
following through the standard operating procedure, GMPs
norms and quality related safety profile. The herbal
manufacturing facilities in India need to be nurtured in
a big way for promotion and development of
phytoceuticals.
Introduction: Traditional medicine (TM) is widely
and increasingly used for a wide spectrum of diseases by
people in both developed and developing countries.
Protection and preservation of traditional medicine
knowledge is essential to ensure access to traditional
forms of health care and respect for those who hold
traditional medicine knowledge. Between 70% and 95% of
developing countries citizens, especially those in Asia,
Africa, Latin America and the Middle East, uses
traditional and folk medicine, for the management of
health. Similarly, the developed country populations
(70% and 90%) are also using traditional medicines under
the titles "complementary", "alternative", or
"nonconventional". It is estimated that at least 25% of
modern medicines are derived, either directly or
indirectly, from medicinal plants, primarily through the
application of modern technology to traditional
knowledge. WHO estimates, the global market for herbal
medicines currently stands at over ~US$60 billion
annually and by the year 2050 it would be ~US$5
trillian1-4 . Indian traditional medicine is based on
various systems, including Ayurveda, Siddha and Unani
(ASU). India is one of the major raw material-producing
nations of South Asia and posses about 8% of the
estimated bio diversity of the world with approximately
8000 medicinal plants species from flowering plants
available in the nature. Many species are used in
Traditional Systems of Medicine as Ayurveda 7000
species, Siddha 600 species, Unani 700 species,
Homeopathy 450 species and Modern medicine 30 species.
Indian Materia Medica includes 2000 natural products of
therapeutic importance of which 400 are of mineral and
animal origin and rest are of vegetable origin. There
are approximately 1250 Indian medicinal plants, which
are used in formulating therapeutic preparation
according to Ayurveda and other traditional system of
medicine5,6.
For full text of this article contact the publisher on
info@kppub.com
|
|
Go to Content Index Page
|
|
The above content is an
abstract only. For the full Article please contact:
KONGPOSH Publications Pvt. Ltd.
ICS House, C-19, Commercial Complex, SDA, Opp. IIT Gate,
New Delhi, India -110016
Tel.: 26855839, 20057149, Fax: 91-11-26855876
Email:
info@kppub.com /
fpc@vsnl.com, Website:
http://www.kppub.com |
|
|
|